AI Insight
Researchers from the University of Cologne, University Hospital Cologne, and the Max Planck Institute for Metabolism Research have developed a novel method to precisely quantify damage in individual cells using molecular markers based on gene expression. This technique allows for detailed analysis of disease progression at the single-cell level in tissue samples such as biopsies, specifically targeting kidney and liver cells. The approach represents the first time that cellular damage can be measured with this level of precision in individual cells rather than tissue averages.
Why it matters
This method could significantly improve diagnostic accuracy for kidney and liver diseases by identifying damaged cells within biopsy samples before widespread tissue damage occurs. The single-cell resolution may enable earlier disease detection, more personalized treatment strategies, and better monitoring of therapeutic responses in patients with organ damage.
Understand the Science
Researchers at the University of Cologne, University Hospital Cologne and the Max Planck Institute for Metabolism Research have developed a method that, for the first time, enables damage to individual cells to be precisely quantified. The method uses molecular markers—specifically gene expression—and enables detailed analysis of disease progression in individual tissue samples, such as a biopsy.
Source: Gene markers quantify damage in individual kidney and liver cells